ARTERY-KY is set to make headlines in the semiconductor industry with its upcoming listing on the Taipei Exchange. The company’s rapid growth, innovative microcontroller technology, and strategic focus on edge AI are drawing attention from investors and tech leaders alike.
ARTERY-KY Set for TPEx Listing and Poised for Strong Growth
ARTERY-KY, a leading 32-bit MCU designer, will be listed on the Taipei Exchange in January 2026. During its pre-IPO investor conference in Taipei, the company highlighted its strengths and ambitious business outlook. ARTERY-KY’s technology, built on ARM® Cortex®-M4 cores, offers an industry-leading clock speed of up to 288 MHz. As a subsidiary of Faraday Technology, it has quickly integrated into the global supply chain, especially within China’s rapidly transforming technology market.
Driving Innovation: High-Performance MCUs and Edge AI Expansion
The company’s technical expertise spans core architecture design, application integration, and an extensive range of markets. ARTERY-KY MCUs are found in industrial automation, motor control, consumer electronics, medical equipment, IoT, and automotive applications. Its high-performance chips deliver low power consumption and excellent cost-effectiveness. Notably, the company is now focusing on emerging technologies such as drones, robotics, and edge AI. Strategic collaborations with UMC and Faraday Technology are helping ARTERY-KY develop advanced platforms using 28-nanometer embedded Flash processes.
Financial Success and Strategic Roadmap for 2026 and Beyond
Recent financials show substantial momentum. In 2024, revenue rose over 60% year-on-year, reaching NT$1.635 billion, with an EPS of NT$1.67. For the first three quarters of 2025, the company set a historic revenue high and improved its gross margin to 33.84%. Net profit after tax hit NT$70.52 million, with EPS up 56%. Looking ahead, ARTERY-KY will:
- Build a comprehensive MCU ecosystem from M0 to M85.
- Expand ASIC-based custom MCU solutions for faster, tailored chip development.
- Pursue edge AI with state-of-the-art 28nm technology.
These strategies show ARTERY-KY’s commitment to sustained growth and innovation.
In summary, ARTERY-KY is positioned for significant growth as it enters the Taipei Exchange. The company’s technological strengths, expanding market applications, and clear strategic vision set it apart in a competitive industry. Investors will be watching closely as ARTERY-KY continues to drive high-performance MCU and edge AI innovation in the years to come.
Don’t miss our latest Startup News: Advantech Edge AI Solutions Set New Standard for Smart Industry
